Norway
Duty free*
- Their lines2 Norwegian lines
30.04.9002 Containing narcotic drugs or psychotropic substances
Norwegian tariff data checked Sept. 13, 2026.
Code 3004 90 · Heading 3004
Dosed or retail-packed therapeutic or preventive medicines, excluding specified medicines and clinical trial sets
This covers medicines made from mixed or unmixed products for therapeutic or preventive use, when supplied in doses—including for transdermal administration—or in forms or packs for retail sale. It does not cover medicines containing antibiotics, hormones or steroids used as hormones, alkaloids, provitamins, vitamins or their derivatives, specified malaria-active ingredients, or sets for clinical blind trials.
For example
- A dosed therapeutic paracetamol medicine containing none of the excluded substances
- A retail-packed preventive medicine made from mixed products and containing none of the excluded substances
See the official tariff text
Official tariff text
Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones or steroids used as hormones, alkaloids, provitamins, vitamins, their derivatives, antimalarial active principles and blinded clinical trial kits)
Show the steps
Pick the 8-digit code
Import duty on the codes below: 0.0%*
Only one code below
3004 90 00
Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones or steroids used as hormones, alkaloids, provitamins, vitamins, their derivatives, antimalarial active principles and blinded clinical trial kits)
Duty free*This subheading has one 8-digit code, so that is the code to use.
Compare the sibling codes
See all 12 codes at this level- 3004 10 Medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale 0.0%*
- 3004 20 Medicaments containing antibiotics, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. medicaments containing penicillins or derivatives thereof with a penicillanic structure, or streptomycines or derivatives thereof) 0.0%*
- 3004 31 Medicaments containing insulin but not antibiotics, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale 0.0%*
- 3004 32 Medicaments containing corticosteroid hormones, their derivatives or structural analogues but not antibiotics, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale 0.0%*
- 3004 39 Medicaments containing hormones or steroids used as hormones but not antibiotics, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. medicaments containing insulin or corticosteroid hormones, their derivatives or structural analogues) 0.0%*
- 3004 41 Medicaments containing ephedrine or its salts, not containing hormones, steroids used as hormones or antibiotics, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale 0.0%*
- 3004 42 Medicaments containing pseudoephedrine "INN" or its salts, not containing hormones, steroids used as hormones or antibiotics, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale 0.0%*
- 3004 43 Medicaments containing norephedrine or its salts, not containing hormones, steroids used as hormones or antibiotics, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale 0.0%*
- 3004 49 Medicaments containing alkaloids or derivatives thereof, not containing hormones, steroids used as hormones or antibiotics, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing ephedrine, pseudoephedrine "INN", norephedrine or their salts) 0.0%*
- 3004 50 Medicaments containing provitamins, vitamins, incl. natural concentrates and derivatives thereof used primarily as vitamins, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones, alkaloids, or their derivatives) 0.0%*
- 3004 60 Medicaments containing any of the following antimalarial active principles: artemisinin "INN" for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine "INN"; artelinic acid or its salts; artenimol "INN"; artemotil "INN"; artemether "INN"; artesunate "INN"; chloroquine "INN"; dihydroartemisinin "INN"; lumefantrine "INN"; mefloquine "INN"; piperaquine "INN"; pyrimethamine "INN" or sulfadoxine "INN", put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones, alkaloids, provitamins, vitamins, or their derivatives) 0.0%*
-
3004 90 Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones or steroids used as hormones, alkaloids, provitamins, vitamins, their derivatives, antimalarial active principles and blinded clinical trial kits) you are here 0.0%*
Selling to Norway, Great Britain and the United States
What they charge on arrival.
Norway, Great Britain and the United States use their own tariff lines under the 6-digit HS code. The rates below are what their customs charge on goods arriving from the EU. Match the goods against each country's own wording before you rely on a rate.
Great Britain
Duty free*
- Their lines1 British line
3004 90 00 00 Other
Northern Ireland follows other rules.
UK tariff data checked Sept. 13, 2026.
United States
0.0% or 15.0%†
Depends on a question
- Their lines75 US lines
- Entry dateSept. 17, 2026
3004.90.10.00 Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed
The US importer of record files the entry.
US tariff data checked Sept. 16, 2026.
See the 2 Norwegian lines
Selling to Norway
Norway splits the 6-digit category its own way, so these are Norway's own lines under it, not this EU code. Check your product against their wording; what Norwegian customs charges is shown per line.
-
30.04.9002
Containing narcotic drugs or psychotropic substances
- Ordinary duty
- Duty free*
-
30.04.9008
Other
- Ordinary duty
- Duty free*
Contains data from Norwegian Customs (data.toll.no), licensed under CC BY 4.0, adapted for display.
See the 1 British line
Selling to Great Britain
What UK customs charges when goods like these arrive in Great Britain.
-
3004 90 00 00
Other
- Ordinary duty
- Duty free*
These rates apply in Great Britain. Different rules may apply for goods entering Northern Ireland.
Contains public sector information licensed under the Open Government Licence v3.0.
Source: UK Department for Business and Trade (data.api.trade.gov.uk).
See the 75 US lines
Selling to the United States
What US customs charges when goods like these arrive from the EU. The US importer of record files the entry and pays the duty.
-
3004.90.10.00
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Containing antigens or hyaluronic acid or its sodium salt
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.01
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, For veterinary use
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.03
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antivirals, Containing acyclovir or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.04
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antivirals, Containing oseltamivir or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.05
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antivirals, Containing valganciclovir, peramivir or their salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.06
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antivirals, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.07
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antifungals, Containing fluconazole or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.08
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antifungals, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
Show all 75 lines
-
3004.90.92.09
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antiprotozoals (excluding goods described in subheading note 2 to this chapter), Containing metronidazole or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.10
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antiprotozoals (excluding goods described in subheading note 2 to this chapter), Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.11
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Sulfonamides, Containing trimethoprim and sulfamethoxazole or their salts
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.12
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Sulfonamides, Other
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.13
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Other, Containing levofloxacin or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.14
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Other, Containing linezolid or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.15
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.16
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Antineoplastic and immunosuppressive medicaments, Containing hydroxyurea or cyclophosphamide or their salts
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.17
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Antineoplastic and immunosuppressive medicaments, Containing tacrolimus or mycophenolate mofetil or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.18
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Antineoplastic and immunosuppressive medicaments, Other
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.19
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing metoprolol or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.20
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing amiodarone or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.21
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing diltiazem or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.22
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing hydralazine or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.23
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing enoxaparin or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.24
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing labetalol or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.25
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing argatroban, adenosine, amlodipine, esmolol, dobutamine, phenoxybenzamine or their salts
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.26
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Other
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.27
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Tolmetin
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.28
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Tolmetin sodium dihydrate
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.29
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Tolmetin sodium (anhydrous)
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.30
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing ibuprofen or its salts, For oral suspension
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.31
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing ibuprofen or its salts, Other
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.32
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing acetaminophen or its salts, For oral suspension
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.33
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing acetaminophen or its salts, Other
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.34
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing O-Acetylsalicylic acid (Aspirin)
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.35
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing tramadol
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.36
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.37
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing dexmedetomidine, etomidate, midazolam, propofol or their salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.38
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing midazolam or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.39
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing phenytoin or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.40
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing propofol or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.41
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing levetiracetam, phenytoin or their salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.42
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing etomidate or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.43
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.44
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Antidepressants, tranquilizers, and other psychotherapeutic agents, Containing lorazepam or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.45
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Antidepressants, tranquilizers, and other psychotherapeutic agents, Containing olanzapine or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.46
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Antidepressants, tranquilizers, and other psychotherapeutic agents, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.47
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Other, Containing rocuronium or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.48
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Other, Containing succinylcholine or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.49
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.50
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Dermatological agents and local anesthetics, Containing lidocaine or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.51
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Dermatological agents and local anesthetics, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.52
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Laxatives
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.53
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Antacids
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.54
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing famotidine or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.55
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing pantoprazole or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.56
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing ondansetron or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.57
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing glycopyrrolate or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.58
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing loperamide or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.60
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.61
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Diuretics, Containing furosemide and its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.62
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Diuretics, Containing hydrochlorothiazide or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.63
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Diuretics, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.64
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other, Containing calcium gluconate
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.65
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other, Containing potassium chloride
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.66
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other, Containing sodium bicarbonate, in injection form
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.67
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.68
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Cough and cold preparations
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.69
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Antihistamines, Containing diphenhydramine or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.70
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Antihistamines, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.71
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Containing albuterol sulfate
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.72
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Containing timolol maleate
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.73
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.74
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Containing heparin sodium or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.75
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Containing zoledronic acid or its salts
- General rate
- Free
- From the EU
- 0.0%† Estimated from published US measures US headings applied: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
-
3004.90.92.76
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other
- General rate
- Free
- From the EU
- 0.0% or 15.0%† Depends on a question US headings applied: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
Anti-dumping and countervailing duties, US import taxes and customs fees are not included.
The descriptions above are the US tariff texts, which the United States publishes in English only.
Source: the US International Trade Commission's Harmonized Tariff Schedule (hts.usitc.gov), public domain, and the measures published in the Federal Register.
This is a planning estimate from the US Harmonized Tariff Schedule (revision shown) and the published Federal Register measures as of the date shown, for a shipment of EU origin. It is not a customs entry, legal advice or a broker's opinion, and tariffs.help is not a US-licensed customs broker. The US importer of record or their broker confirms the classification, origin, value and the duty due before filing.
Duty rates shown here are estimates, read from official EU / Danish, Norwegian and UK tariff data for orientation only. Confirm the current rate with Toldstyrelsen, TARIC, Norwegian Customs or the UK Online Trade Tariff before you file. The rate you pay can also depend on the country of origin. These are base customs duties only: import VAT, excise duties, anti-dumping duties and safeguard or quota measures are not included.
Save codes to your own collection
Create a free account to keep the customs codes you care about in one place, and come back to them whenever you need them.